Calyx and Invicro are now Perceptive
Independent review of trial event assessments by adjudication experts.
Proven expertise in delivering high-quality imaging data at a global scale.
With strengths in instrument engineering, signal processing, and pharmaceutical R&D, Perceptive Discovery consistently delivers successful imaging study designs and executions.
Effective RTSM, built on 30 years of experience, and connected to an ecosystem which includes eConsent and eCOA.
Highly established imaging centers for first-in-human and multicenter trials.
900+ agents radiolabeled and counting.
Supporting both malignant and non-malignant indications.
Experts in Alzheimer’s Disease, Parkinson’s Disease imaging and more.
Supporting over 85% of radiopharmaceutical companies.
Optimize preclinical and clinical trials in other areas and drug classifications.
Therapeutic and technical expertise in imaging modalities, protocol design, and acquisition.
Oncology imaging, RTSM, and clinical adjudication services.
Tackling unique rare disease trial supply, imaging and adjudication challenges.
We are here to serve science.
From discovery, through early to late-phase clinical development, to regulatory approval and post-market, you can count on Perceptive to be dependable, diligent, and driven in everything we do.
Perceptive Discovery bridges preclinical insights to early clinical success, ensuring rigorous scientific analysis and high-quality data to support innovation.
Providing the right-fit randomization & trial supply management solution for your trials, delivered by experts.
The right people, experience, and technology to drive clinical trial imaging success.
Delivering precision and efficiency for all your radiochemistry needs.
Our radiochemistry team has radiolabeled hundreds of biological agents and small molecules for preclinical and clinical trial imaging. From targeted small molecules to monoclonal antibodies, peptides, and live cell labeling, we provide expertise across a diverse range of chemical entities.
Additionally, we offer ligand discovery support, leveraging our in-house expertise to optimize candidate selection.
Our radiochemistry services are designed to reliably deliver high-quality radiotracers tailored precisely to meet your project needs.
Perceptive has extensive experience working with widely used SPECT/PET and therapeutic isotopes.
We also support conjugation with fluorophores as well as ‘cold’ radiolabeling with non-radioactive elements.
Common SPECT isotopes
99mTc, 123I, 111In, 201Tl*, 177Lu*, 131I*
*Non-clinical use only
Common PET isotopes
11C, 68Ga, 18F, 64Cu, 89Zr, 124I*, 52Mn*
Other available isotopes
213Bi*, 90Y*, 225Ac*, 67Cu, 161Tb, 212Pb, 188Re, 3H*, 14C*
Other isotopes available, please inquire.
Perceptive provides extensive support for small molecule ligand development, offering guidance on candidate selection from sponsor compound libraries or the production of custom precursors and standards for preclinical studies to maximize your chances of success. We also facilitate custom GMP precursor manufacturing through our trusted partners.
Perceptive offers in-house radiochemistry and clinical services, oversees clinical manufacturing at external sites, and produces and supplies radiotracers to imaging sites across the US and UK. We also facilitate access to a global network of radiotracer manufacturers, enabling GMP manufacturing at one of our sites with subsequent technology transfer to one of many perceptive-qualified sites based on geographical needs.
Our team also has extensive experience collaborating with external manufacturers to optimize and advance new tracers for IND applications and support NDA submissions for commercial use.
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
Highly established clinical and imaging centers supporting first-in-human and multicenter studies.
Proven expertise in delivering high-quality clinical trial imaging data at a global scale.
